
Key points:
·IQOS ILUMA i officially enters the Bulgarian market, featuring three models: "IQOS ILUMA i PRIME","IQOS ILUMA i" and "IQOS ILUMA i One."
·With over 450,000 IQOS users in Bulgaria, the country has become a key driver for product upgrades and local market expansion.
· Philip Morris International (PMI) states that they are continuously investing in technology and product development to provide adult smokers with better smoke-free alternatives.
According to reports from Economic on April 24th, Philip Morris International (PMI) Bulgaria has recently launched the heated tobacco device "IQOS ILUMA i".
"IQOS ILUMA i" has launched three device models, "IQOS ILUMA i PRIME","IQOS ILUMA i"and "IQOS ILUMA i One", with a variety of colors and accessories to choose from.

The General Manager of Philip Morris International's (PMI) Bulgaria company, Denis Strobikin, stated that the IQOS ILUMA i is elevating the smoke-free product experience to new heights. The company remains committed to driving innovation in smoke-free alternatives based on science, providing adult smokers in Bulgaria and globally with a reduced harm choice.
Polina Ninova, Market and Consumer Experience Manager for Phillip Morris International (PMI), stated:
"The Bulgarian market currently has over 450,000 IQOS users, who have provided key feedback on product experience, serving as an important basis for driving continuous innovation for the brand. Compared to its predecessor, the ILUMA i is more intuitive and adjustable, representing a new upgraded version tailored to the actual needs of users."
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.